Korra Energi has been awarded the exciting project of constructing the first biopharmaceutical manufacturing facility in Egypt, Africa, and the Middle East! This groundbreaking collaboration with Mina Pharm and Pro-biogen Germany will bring cutting-edge vaccine production to the region.
Korra Energi’s proven expertise and engineering capabilities make them the ideal partner for this complex project. They fully understand the precise requirements, mandates, and quality standards necessary for such a facility.
_______
Scope
Korra Energi will handle the entire electromechanical works for the facility on a turnkey basis. This encompasses everything from initial engineering design to final operation, commissioning, and handover to the Ministry of Health.
Furthermore, Korra Energi’s success with Mina Pharm extends beyond this initial project. They have also been awarded the second phase, which involves producing 40 million Sputnik (Covid-19) vaccine doses annually. This demonstrates their ongoing commitment and expertise in this critical field.